Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on March 27, 2025
First Atlantic Nickel Intersects 0.25% Nickel and 0.29% Chromium in Second Discovery Drill Hole at RPM Zone, Confirming Mineralized Width of 300 Meters, with Nickel Grade Increasing to 0.27% in Final 21 Meters Into Fault Zone
GlobeNewswire
·
March 27, 2025
VANCOUVER, British Columbia, March 27, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") is pleased to announce the assay results from drill hole AN-24-03, the third drill hole of …
Pleco Therapeutics gibt positives Ergebnis des Pre-IND-Meetings mit der FDA für PTX-252 bei akuter myeloischer Leukämie bekannt
GlobeNewswire
·
March 27, 2025
NIJMEGEN, Niederlande, March 27, 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, ein im klinischen Stadium tätiges Biopharmazieunternehmen, das neuartige Therapien für schwer zu behandelnde Krebserkrankungen entwickelt, gibt ein positives Ergebnis seines Pre- …
Pleco Therapeutics annonce un résultat positif de sa réunion de pré-IND avec la FDA pour la poursuite du développement du PTX-252 dans le cadre du traitement de la leucémie myéloïde aiguë
GlobeNewswire
·
March 27, 2025
NIMÈGE, Pays-Bas, 27 mars 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, société biopharmaceutique de phase clinique qui développe des thérapies innovantes pour les cancers difficiles à traiter, annonce un résultat positif de sa réunion de pré-IND (Pre- …
Discovery Reports Fourth Quarter & Full-Year 2024 Financial Results
GlobeNewswire
·
March 27, 2025
TORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced financial results for the three months (“Q4 2024”) and full-year (“FY 2024”) ended December 31, 2024. All figures are …
Ryoncil® is Now Available for Purchase in the United States
GlobeNewswire
·
March 27, 2025
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that Ryoncil® (remestemcel-L) the first mesenchymal stromal cell (MSC) therapy …